We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$169M
Cap. Flow
+$103M
Cap. Flow %
19.96%
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.25M
2
GILD icon
Gilead Sciences
GILD
+$6.13M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.05M
4
AMGN icon
Amgen
AMGN
+$5.9M
5
ADBE icon
Adobe
ADBE
+$5.02M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.85M
2
ADI icon
Analog Devices
ADI
+$3.37M
3
AMZN icon
Amazon
AMZN
+$3.21M
4
LULU icon
lululemon athletica
LULU
+$2.87M
5
ORCL icon
Oracle
ORCL
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Healthcare 30.05%
3 Consumer Discretionary 17.55%
4 Communication Services 6.11%
5 Consumer Staples 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIRM icon
226
Mirum Pharmaceuticals
MIRM
$6.04B
$159K 0.03%
5,394
+4,408
+447% +$133K
ZLAB icon
227
Zai Lab
ZLAB
$2.86B
$159K 0.03%
5,802
+4,431
+323% +$117K
MELI icon
228
Mercado Libre
MELI
$92.7B
$157K 0.03%
100
-87
-47% -$123K
RLAY icon
229
Relay Therapeutics
RLAY
$4.4B
$157K 0.03%
14,257
+11,122
+355% +$93.9K
SRRK icon
230
Scholar Rock
SRRK
$6.55B
$157K 0.03%
8,346
+6,905
+479% +$85.8K
VIR icon
231
Vir Biotechnology
VIR
$1.52B
$157K 0.03%
15,560
+12,112
+351% +$111K
APGE icon
232
Apogee Therapeutics
APGE
$10.2B
$155K 0.03%
+5,555
New +$111K
GMAB icon
233
Genmab
GMAB
$19.6B
$154K 0.03%
4,845
+3,770
+351% +$118K
PTGX icon
234
Protagonist Therapeutics
PTGX
$9.84B
$153K 0.03%
6,675
+5,202
+353% +$91K
AKRO
235
DELISTED
Akero Therapeutics
AKRO
$151K 0.03%
6,449
+5,023
+352% +$99.1K
SAGE
236
DELISTED
Sage Therapeutics
SAGE
$150K 0.03%
6,937
+5,406
+353% +$107K
DCPH
237
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$150K 0.03%
9,272
+7,246
+358% +$92.4K
XNCR icon
238
Xencor
XNCR
$1.72B
$149K 0.03%
7,041
+5,493
+355% +$105K
AUPH icon
239
Aurinia Pharmaceuticals
AUPH
$2.06B
$149K 0.03%
16,613
+12,940
+352% +$107K
VEEV icon
240
Veeva Systems
VEEV
$39.2B
$148K 0.03%
771
-7,497
-91% -$1.41M
DAWN
241
DELISTED
Day One Biopharmaceuticals
DAWN
$147K 0.03%
10,067
+7,841
+352% +$95.1K
CDNS icon
242
Cadence Design Systems
CDNS
$89B
$147K 0.03%
538
-475
-47% -$122K
AVDL
243
DELISTED
Avadel Pharmaceuticals
AVDL
$146K 0.03%
10,327
+8,029
+349% +$94.3K
AGIO icon
244
Agios Pharmaceuticals
AGIO
$2.04B
$144K 0.03%
6,469
+5,040
+353% +$113K
LGND icon
245
Ligand Pharmaceuticals
LGND
$5.85B
$144K 0.03%
2,012
+1,571
+356% +$92.7K
BCRX icon
246
BioCryst Pharmaceuticals
BCRX
$2.71B
$142K 0.03%
23,692
+18,827
+387% +$109K
KROS icon
247
Keros Therapeutics
KROS
$222M
$138K 0.03%
3,460
+2,702
+356% +$84.7K
CSX icon
248
CSX Corp
CSX
$92.8B
$137K 0.03%
3,939
-3,537
-47% -$113K
GERN icon
249
Geron
GERN
$1.01B
$133K 0.03%
62,820
+49,394
+368% +$96.1K
MAR icon
250
Marriott International
MAR
$92.5B
$131K 0.03%
583
-528
-48% -$107K
8 9
10
11 12

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, China Universal Asset Management Company held 503 positions worth $514M, up 49% from $345M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

China Universal Asset Management Company deployed $103M of net new capital in Q4 2023, opening 57 new positions and adding to 239 existing holdings. Its largest new stake was GSK: 54,345 shares worth $2.03M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $4.85M trimmed.

  • China Universal Asset Management Company's largest Q4 2023 buy was GSK: 54,345 shares worth $2.03M.
  • China Universal Asset Management Company added most to Vertex Pharmaceuticals in Q4 2023, an estimated $6.25M increase.
  • China Universal Asset Management Company's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $4.85M.
  • China Universal Asset Management Company fully exited Oracle in Q4 2023, selling an estimated $1.91M.
  • China Universal Asset Management Company's ten largest holdings make up 27% of its $514M portfolio in Q4 2023.
  • China Universal Asset Management Company opened 57 new positions and closed 78 in Q4 2023.
  • China Universal Asset Management Company's portfolio value rose 49% quarter-over-quarter to $514M.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.